Recent work in a chronic viral infection model demonstrated that IL-2 influences the differentiation of stem-like CD8+ T cells, creating distinct sets of PD-1+CD8+ effector T cells with superior antiviral activity as compared to PD-1 blockade treatment alone. Here, CD8A is linked to viral infectious disease.